Je. Barrett et al., ANXIOLYTIC AND ANTIDEPRESSANT MECHANISMS OF 5-HT1A DRUGS IN THE PIGEON - CONTRIBUTIONS FROM BEHAVIORAL-STUDIES, Neuroscience and biobehavioral reviews, 18(1), 1994, pp. 73-83
The discovery that compounds acting through 5-hydroxytryptamine (5-HT)
receptor subtypes can produce anxiolytic and/or antidepressant therap
eutic effects in humans has resulted in considerable interest in the r
ole of the 5-HT receptor system in both anxiety and depressive disorde
rs. Because many of the clinically efficacious 5-HT1A anxiolytic drugs
are either ineffective or produce inconsistent results in traditional
or standard types of preclinical punishment or conflict procedures wi
th rodents and other nonhuman mammals, there is considerable need for
alternative behavioral assays sensitive to and selective for these com
pounds. In contrast to data with nonhuman mammals, 5-HT1A drugs are qu
ite effective in pigeons studied under a punishment procedure. This pa
per reviews the use of the pigeon conflict procedure as a method for t
he detection and analysis of potential anxiolytic drugs acting through
5-HT1A receptors. Additionally, recent studies, also with the pigeon,
have indicated that, in contrast to the rat, it is possible to establ
ish an antidepressant such as imipramine as a discriminative stimulus,
and then to use this procedure to evaluate the neuropharmacological b
ases for the behavioral and, presumably, therapeutic actions of these
drugs. Using the drug discrimination procedure, it has been possible t
o examine a number of selective compounds that substitute for imiprami
ne, thereby clarifying specific substrates for the antidepressant acti
vity of this and related drugs. The pigeon promises to be a useful spe
cies in the pharmacological analyses of novel anxiolytic drugs and pro
vides new approaches to the analysis and understanding of traditional
as well as the more recently introduced antidepressant drugs.